{"data":[{"accessionNo":"0001172661-26-003535","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Shares, No Par Value per Share","eventDate":"2026-06-30","reportingPerson":"Great Point Partners, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":736881,"percentOfClass":7.66,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-003535","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Shares, No Par Value per Share","eventDate":"2026-06-30","reportingPerson":"Dr. Jeffrey R. Jay, M.D.","reportingCik":null,"personType":"HC,IN","sharesOwned":736881,"percentOfClass":7.66,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-003535","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Shares, No Par Value per Share","eventDate":"2026-06-30","reportingPerson":"Ms. Lillian Nordahl","reportingCik":null,"personType":"HC,IN","sharesOwned":736881,"percentOfClass":7.66,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0000902219-26-000224","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences, Inc.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":696378,"percentOfClass":7.8,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0000902219-26-000224","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences, Inc.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":696378,"percentOfClass":7.8,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0000902219-26-000224","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences, Inc.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":696378,"percentOfClass":7.8,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0000902219-26-000224","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences, Inc.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":696378,"percentOfClass":7.8,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001903360-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences, Inc.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":696378,"percentOfClass":7.8,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0000902219-26-000122","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences, Inc.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":895871,"percentOfClass":10,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0000902219-26-000122","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences, Inc.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":895871,"percentOfClass":10,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0000902219-26-000122","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences, Inc.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":895871,"percentOfClass":10,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0000902219-26-000122","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences, Inc.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":895871,"percentOfClass":10,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-002037","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Shares, No Par Value per Share","eventDate":"2026-03-31","reportingPerson":"Ms. Lillian Nordahl","reportingCik":null,"personType":"HC,IN","sharesOwned":954082,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-002037","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Shares, No Par Value per Share","eventDate":"2026-03-31","reportingPerson":"Dr. Jeffrey R. Jay, M.D.","reportingCik":null,"personType":"HC,IN","sharesOwned":954082,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-002037","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Shares, No Par Value per Share","eventDate":"2026-03-31","reportingPerson":"Great Point Partners, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":954082,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001104659-26-057168","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":"74346M406","securityClass":"Common Shares, No Par Value","eventDate":"2026-03-31","reportingPerson":"Title 19 Promis","reportingCik":null,"personType":"OO","sharesOwned":181632,"percentOfClass":2,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001104659-26-057168","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":"74346M406","securityClass":"Common Shares, No Par Value","eventDate":"2026-03-31","reportingPerson":"Michael S. Gordon","reportingCik":null,"personType":"IN","sharesOwned":181632,"percentOfClass":2,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001274173-26-000104","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Shares","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":1292757,"percentOfClass":14.4,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001903360-26-000013","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences, Inc.","ticker":"PMN","cusip":"74346M505","securityClass":"Common Stock","eventDate":"2026-03-11","reportingPerson":"Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":895877,"percentOfClass":9.99,"filedAt":"2026-03-18","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-001139","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Great Point Partners, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":409648,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-001139","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Dr. Jeffrey R. Jay, M.D.","reportingCik":null,"personType":"HC,IN","sharesOwned":409648,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-001139","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Ms. Lillian Nordahl","reportingCik":null,"personType":"HC,IN","sharesOwned":409648,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-001223","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":504673,"percentOfClass":0.93,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-001223","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":504673,"percentOfClass":0.93,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005965","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"Trails Edge Biotechnology Master Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":933477,"percentOfClass":9.9,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005965","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"Ortav Yehudai","reportingCik":null,"personType":"IN","sharesOwned":933477,"percentOfClass":9.9,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005965","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"Trails Edge Capital Partners, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":933477,"percentOfClass":9.9,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-000524","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-01-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":902561,"percentOfClass":9.99,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-000524","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-01-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":902561,"percentOfClass":9.99,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-000524","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-01-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":703457,"percentOfClass":7.79,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-26-000524","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-01-30","reportingPerson":"Deep Track Special Opportunities Fund, LP.","reportingCik":null,"personType":"PN","sharesOwned":199104,"percentOfClass":2.2,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005412","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"Fan Yu","reportingCik":"0001668029","personType":"IN","sharesOwned":1644397,"percentOfClass":17,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001178913-26-000313","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Sphera Global Healthcare GP Ltd.","reportingCik":null,"personType":"CO","sharesOwned":180697.52,"percentOfClass":7.78,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001178913-26-000313","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Sphera Global Healthcare Management LP.","reportingCik":null,"personType":"PN","sharesOwned":180697.52,"percentOfClass":7.78,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001178913-26-000313","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Sphera Funds Management Ltd.","reportingCik":null,"personType":"CO","sharesOwned":180697.52,"percentOfClass":7.78,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005412","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"Ally Bridge Group Global Life Science Capital Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":659520,"percentOfClass":7.1,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005412","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"ABG Global Life Science Capital Partners V GP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":659520,"percentOfClass":7.1,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005412","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"ABG Global Life Science Capital Partners V GP Limited","reportingCik":null,"personType":"CO","sharesOwned":659520,"percentOfClass":7.1,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005412","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"ABG V-SIV IX Limited","reportingCik":null,"personType":"CO","sharesOwned":659520,"percentOfClass":7.1,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005412","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"Ally Bridge MedAlpha Master Fund L.P.","reportingCik":"0001831963","personType":"PN","sharesOwned":572677,"percentOfClass":6.3,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005412","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"ABG Management Ltd.","reportingCik":"0001832106","personType":"CO","sharesOwned":572677,"percentOfClass":6.3,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005412","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"Ally Bridge Group (NY) LLC","reportingCik":"0001822947","personType":"OO","sharesOwned":572677,"percentOfClass":6.3,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-005412","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-03","reportingPerson":"ABG V-SIV X Limited","reportingCik":null,"personType":"CO","sharesOwned":412200,"percentOfClass":4.5,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-004760","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-01-29","reportingPerson":"ABG Management Ltd.","reportingCik":"0001832106","personType":"CO","sharesOwned":6070405,"percentOfClass":11.3,"filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-004760","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-01-29","reportingPerson":"Ally Bridge Group (NY) LLC","reportingCik":"0001822947","personType":"OO","sharesOwned":6070405,"percentOfClass":11.3,"filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-004760","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-01-29","reportingPerson":"Ally Bridge MedAlpha Master Fund L.P.","reportingCik":"0001831963","personType":"PN","sharesOwned":6070405,"percentOfClass":11.3,"filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-26-004760","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-01-29","reportingPerson":"Fan Yu","reportingCik":"0001668029","personType":"IN","sharesOwned":6070405,"percentOfClass":11.3,"filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001814554-25-000176","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-09-30","reportingPerson":"Ms. Lillian Nordahl","reportingCik":null,"personType":"HC,IN","sharesOwned":5972369,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001814554-25-000176","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-09-30","reportingPerson":"Great Point Partners, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":5972369,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001814554-25-000176","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-09-30","reportingPerson":"Dr. Jeffrey R. Jay, M.D.","reportingCik":null,"personType":"HC,IN","sharesOwned":5972369,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-25-005157","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-09-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":2974518,"percentOfClass":5.53,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001172661-25-005157","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001374339","issuerName":"PROMIS NEUROSCIENCES INC.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-09-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":2974518,"percentOfClass":5.53,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-25-020081","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-10-22","reportingPerson":"ABG Management Ltd.","reportingCik":"0001832106","personType":"CO","sharesOwned":6070405,"percentOfClass":11.3,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-25-020081","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-10-22","reportingPerson":"Ally Bridge Group (NY) LLC","reportingCik":"0001822947","personType":"OO","sharesOwned":6070405,"percentOfClass":11.3,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-25-020081","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-10-22","reportingPerson":"Ally Bridge MedAlpha Master Fund L.P.","reportingCik":"0001831963","personType":"PN","sharesOwned":6070405,"percentOfClass":11.3,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001493152-25-020081","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-10-22","reportingPerson":"Fan Yu","reportingCik":"0001668029","personType":"IN","sharesOwned":6070405,"percentOfClass":11.3,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001178913-25-003546","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-09-30","reportingPerson":"Sphera Funds Management Ltd.","reportingCik":null,"personType":"CO","sharesOwned":3122090,"percentOfClass":5.51,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001178913-25-003546","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-09-30","reportingPerson":"Sphera Global Healthcare GP Ltd.","reportingCik":null,"personType":"CO","sharesOwned":3122090,"percentOfClass":5.51,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001178913-25-003546","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2025-09-30","reportingPerson":"Sphera Global Healthcare Management LP.","reportingCik":null,"personType":"PN","sharesOwned":3122090,"percentOfClass":5.51,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001104659-25-099789","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, No Par Value per Share","eventDate":"2025-09-30","reportingPerson":"Jeremy M. Sclar","reportingCik":null,"personType":"IN","sharesOwned":9511930,"percentOfClass":16.9,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001104659-25-099789","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, No Par Value per Share","eventDate":"2025-09-30","reportingPerson":"Jeremy M. Sclar 2012 Irrevocable Family Trust","reportingCik":null,"personType":"OO","sharesOwned":7541103,"percentOfClass":13.6,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"},{"accessionNo":"0001104659-25-099789","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001374339","issuerName":"ProMIS Neurosciences Inc.","ticker":"PMN","cusip":null,"securityClass":"Common Shares, No Par Value per Share","eventDate":"2025-09-30","reportingPerson":"Crocker Mountain LLC","reportingCik":null,"personType":"OO","sharesOwned":1905827,"percentOfClass":3.6,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmn"}],"updatedAt":"2026-11-04T05:24:49.866Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/pmn","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}